MedPath

Dietary Treatment for IBS Within Primary Health Care

Not Applicable
Recruiting
Conditions
Irritable Bowel Syndrome
Registration Number
NCT05415488
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

Irritable bowel syndrome (IBS) is a multifaceted disorder where diet plays a pivotal role in symptom generation and management. The traditional dietary advice given to patients in clinical settings are based on the NICE guidelines. Some of the advice included in these guidelines have limited scientific evidence. The aim of this study is to investigate the effectiveness of the traditional dietary advice in IBS, according to the NICE guidelines, within a primary health care setting, where treatment is delivered digitally and in groups of 8-12 individuals. As a sham comparator, one group will receive dietary advice according to the Swedish dietary guidelines regarding healthy eating habits.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Diagnosed with IBS (ROME IV) by physician
  • Age 18-50
  • Ability to read and understand Swedish
  • Signed informed consent
Exclusion Criteria
  • Received dietary treatment for IBS previously
  • Manifestations of other conditions that may explain gastrointestinal symptoms

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of patients with significant symptom reductionFrom baseline vs. 6 weeks after group session

A responder to treatment is defined as having a symptom reduction \>50 measured by IBS-SSS

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dept of Internal Medicine, Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

Dept of Internal Medicine, Sahlgrenska University Hospital
🇸🇪Gothenburg, Sweden
Magnus Simrén, MD, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.